These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 32353358)

  • 1. Pathologic findings in fallopian tubes of women with chronic pelvic pain after Essure placement.
    Rubin A; Chen JF; Veade A; Hagemann IS
    Contraception; 2020 Aug; 102(2):133-136. PubMed ID: 32353358
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical and histopathological correlations in symptomatic patients with salpingectomy for Essure
    Trecourt A; Devouassoux-Shisheboran M; Nohuz E; Cerruto E; Moret S; Hallez D; Miguet-Bensouda C; Chene G
    Eur J Contracept Reprod Health Care; 2023 Aug; 28(4):227-233. PubMed ID: 37365993
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Patient Outcomes Following Injury from Hysteroscopic Sterilization.
    Sills ES; Dalton MM
    Surg Technol Int; 2016 Apr; 28():165-9. PubMed ID: 27042777
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Essure perforation and chronic pelvic pain.
    Moawad N; Mansuria S
    J Minim Invasive Gynecol; 2011; 18(3):285-6. PubMed ID: 21545955
    [No Abstract]   [Full Text] [Related]  

  • 5. Essure® and chronic pelvic pain: a population-based cohort.
    Arjona Berral JE; Rodríguez Jiménez B; Velasco Sánchez E; Povedano Cañizares B; Monserrat Jordan J; Lorente Gonzalez J; Castelo-Branco C
    J Obstet Gynaecol; 2014 Nov; 34(8):712-3. PubMed ID: 24910944
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pre-hysterectomy assessment of immediate tubal occlusion with the third-generation ESSURE insert (ESS505).
    Thiel J; Rattray D; Cher DJ
    J Minim Invasive Gynecol; 2014; 21(6):1055-60. PubMed ID: 24861649
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Essure Permanent Birth Control, Effectiveness and Safety: An Italian 11-Year Survey.
    Franchini M; Zizolfi B; Coppola C; Bergamini V; Bonin C; Borsellino G; Busato E; Calabrese S; Calzolari S; Fantin GP; Giarrè G; Litta P; Luerti M; Mangino FP; Marchino GL; Molinari MA; Scatena E; Scrimin F; Telloli P; Di Spiezio Sardo A
    J Minim Invasive Gynecol; 2017; 24(4):640-645. PubMed ID: 28232037
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discordant relationship between Essure microinsert position and tubal occlusion.
    Hou MY
    BMJ Case Rep; 2016 Jul; 2016():. PubMed ID: 27466315
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Does Essure Cause Significant De Novo Pain? A Retrospective Review of Indications for Second Surgeries After Essure Placement.
    Kamencic H; Thiel L; Karreman E; Thiel J
    J Minim Invasive Gynecol; 2016; 23(7):1158-1162. PubMed ID: 27569594
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Perioperative findings and complications in Essure® removal surgery.
    Horsten DL; van Gastel DM; Maassen LW; Koks CAM; Veersema S; Bongers MY
    Eur J Obstet Gynecol Reprod Biol; 2021 Aug; 263():1-6. PubMed ID: 34129961
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incidence and risk factors for chronic pelvic pain after hysteroscopic sterilization.
    Yunker AC; Ritch JM; Robinson EF; Golish CT
    J Minim Invasive Gynecol; 2015; 22(3):390-4. PubMed ID: 24952343
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Technique for the Laparoscopic Removal of Essure Microinserts.
    Mahmoud MS
    J Minim Invasive Gynecol; 2016; 23(4):472. PubMed ID: 26776673
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ASIA (Shoenfeld's syndrome) due to hysteroscopic Essure sterilization.
    Chauhan U; Cassidy B; Cohen Tervaert JW
    Autoimmun Rev; 2021 Dec; 20(12):102979. PubMed ID: 34752966
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Laparoscopic removal of Essure device techniques, perioperative findings and evaluation of patient's satisfaction: A case series.
    Antoun L; Smith P; Buduru I; Clark TJ
    J Gynecol Obstet Hum Reprod; 2023 May; 52(5):102567. PubMed ID: 36868503
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Essure Surgical Removal and Subsequent Symptom Resolution: Case Series and Follow-Up Survey.
    Brito LG; Cohen SL; Goggins ER; Wang KC; Einarsson JI
    J Minim Invasive Gynecol; 2015; 22(5):910-3. PubMed ID: 25843521
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Imaging findings in Essure-related complications: a pictorial review.
    Djeffal H; Blouet M; Pizzoferato AC; Vardon D; Belloy F; Pelage JP
    Br J Radiol; 2018 Oct; 91(1090):20170686. PubMed ID: 29927633
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The safety and effectiveness of a new hysteroscopic method for permanent birth control: results of the first Essure pbc clinical study.
    Kerin JF; Carignan CS; Cher D
    Aust N Z J Obstet Gynaecol; 2001 Nov; 41(4):364-70. PubMed ID: 11787907
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Essure Removal for the Treatment of Device-Attributed Symptoms: An Expanded Case Series and Follow-up Survey.
    Clark NV; Rademaker D; Mushinski AA; Ajao MO; Cohen SL; Einarsson JI
    J Minim Invasive Gynecol; 2017; 24(6):971-976. PubMed ID: 28599885
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tubal risk markers for failure to place transcervical sterilization coils.
    Leyser-Whalen O; Rouhani M; Rahman M; Berenson AB
    Contraception; 2012 Apr; 85(4):384-8. PubMed ID: 22036044
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Surgical aspects of removal of Essure microinsert.
    Albright CM; Frishman GN; Bhagavath B
    Contraception; 2013 Sep; 88(3):334-6. PubMed ID: 23290426
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.